Indeed, beyond the activity of Plasmodium GPIs as insulin mimetics [8–10], little is known of how malaria might alter the pathology of T2D and how treatment of T2D might impact malaria infection and, more specifically, transmission. The gene discussed is INS; the disease is malaria.